Guggenheim Assumes Neurocrine Bio. (NBIX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 144.21 +1.03 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.18 | 52 Week High | $58.46 | |||
| Open | $142.94 | 52 Week Low | $31.25 | |||
| Day High | $146.92 | P/E | N/A | |||
| Day Low | $142.48 | EPS | $-0.69 | |||
| Volume | 1,748,230 | |||||
